{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:58:52Z","timestamp":1785841132343,"version":"3.56.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U24DK097771"],"award-info":[{"award-number":["U24DK097771"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["LY2439821"],"award-info":[{"award-number":["LY2439821"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002387","name":"NCI","doi-asserted-by":"publisher","award":["CA125123"],"award-info":[{"award-number":["CA125123"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002387","name":"NCI","doi-asserted-by":"publisher","award":["CA184427"],"award-info":[{"award-number":["CA184427"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jid.2023.03.1658","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T12:13:31Z","timestamp":1679660011000},"page":"1689-1699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1099-7863","authenticated-orcid":false,"given":"Scott A.","family":"Ochsner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-6264","authenticated-orcid":false,"given":"Mesias","family":"Pedroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-0568","authenticated-orcid":false,"given":"Rudolf T.","family":"Pillich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-6598","authenticated-orcid":false,"given":"Venkatesh","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-6519","authenticated-orcid":false,"given":"Bruce W.","family":"Konicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-5138","authenticated-orcid":false,"given":"Ernst R.","family":"Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5833-3452","authenticated-orcid":false,"given":"So Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0053-2803","authenticated-orcid":false,"given":"Sandeep K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6689-0104","authenticated-orcid":false,"given":"Neil J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.03.1658_bib1","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1038\/s41598-018-29472-w","article-title":"RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways","volume":"8","author":"Ahn","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2023.03.1658_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56991","article-title":"Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis","volume":"9","author":"Benezeder","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jid.2023.03.1658_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052242","article-title":"Cross-study homogeneity of psoriasis gene expression in skin across a large expression range","volume":"8","author":"Bigler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.03.1658_bib4","doi-asserted-by":"crossref","first-page":"100281","DOI":"10.1016\/j.jhepr.2021.100281","article-title":"A\u00a0human liver chimeric mouse model for non-alcoholic fatty liver disease","volume":"3","author":"Bissig-Choisat","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jid.2023.03.1658_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/bjd.19509","article-title":"A\u00a0head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial","volume":"184","author":"Blauvelt","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/10.17.1793","article-title":"Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies","volume":"10","author":"Bowcock","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.03.1658_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.03.1658_bib9","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.2147\/JIR.S373150","article-title":"Potential pathogenetic role of antimicrobial peptides carried by extracellular vesicles in an in\u00a0vitro psoriatic model","volume":"15","author":"Capriotti","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.jid.2023.03.1658_bib10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaci.2012.06.044","article-title":"Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation","volume":"130","author":"Choy","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2014.04.019","article-title":"Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions","volume":"40","author":"Di Meglio","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2023.03.1658_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/cdd.2017.172","article-title":"Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM","volume":"25","author":"Engeland","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jid.2023.03.1658_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2023.03.1658_bib14","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/jid.2009.173","article-title":"Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin","volume":"129","author":"Gudjonsson","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/art.39950","article-title":"Gene expression and pharmacodynamic changes in 1,760 systemic lupus erythematosus patients from two phase III trials of BAFF blockade with tabalumab","volume":"69","author":"Hoffman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fonc.2018.00223","article-title":"MuvB: A key to cell cycle control in ovarian cancer","volume":"8","author":"Iness","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2023.03.1658_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/jid.2011.267","article-title":"Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes","volume":"132","author":"Jabbari","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bjd.12937","article-title":"Early tissue responses in psoriasis to the antitumour necrosis factor-alpha biologic etanercept suggest reduced interleukin-17 receptor expression and signalling","volume":"171","author":"Johnston","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12864-015-1508-2","article-title":"Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN","volume":"16","author":"Keermann","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jid.2023.03.1658_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/JID.2015.378","article-title":"Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets","volume":"136","author":"Kim","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib22","first-page":"735","article-title":"Differential expression of cyclin D1, Ki-67, pRb, and p53 in psoriatic skin lesions and normal skin","volume":"17","author":"Kim","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jid.2023.03.1658_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00109-005-0721-x","article-title":"Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals","volume":"83","author":"Kulski","year":"2005","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jid.2023.03.1658_bib25","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.03.1658_bib26","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/jid.2014.28","article-title":"Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms","volume":"134","author":"Li","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib27","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00403-014-1450-1","article-title":"B-Myb enhances proliferation and suppresses differentiation of keratinocytes in three-dimensional cell culture","volume":"306","author":"Maruyama","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2023.03.1658_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2353\/ajpath.2007.061067","article-title":"The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis","volume":"171","author":"Mee","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2023.03.1658_bib31","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER version 14: more genomes, a new Panther GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2023.03.1658_bib32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/jid.2012.33","article-title":"Combined use of laser capture microdissection and cDNA microarray analysis identifies locally expressed disease-related genes in focal regions of psoriasis vulgaris skin lesions","volume":"132","author":"Mitsui","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2023.03.1658_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41597-019-0193-4","article-title":"The Signaling Pathways Project, an integrated 'omics KnowledgeBase for mammalian cellular signaling pathways","volume":"6","author":"Ochsner","year":"2019","journal-title":"Sci Data"},{"key":"10.1016\/j.jid.2023.03.1658_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41597-020-00628-6","article-title":"Consensus transcriptional regulatory networks of coronavirus-infected human cells","volume":"7","author":"Ochsner","year":"2020","journal-title":"Sci Data"},{"key":"10.1016\/j.jid.2023.03.1658_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104581","article-title":"Transcriptional regulatory networks of circulating immune cells in type 1 diabetes: A community KnowledgeBase","volume":"25","author":"Ochsner","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jid.2023.03.1658_bib37","doi-asserted-by":"crossref","first-page":"D529","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"Oughtred","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2023.03.1658_bib38","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jid.2019.11.027","article-title":"Molecular and cellular responses to the TYK2\/JAK1 inhibitor PF-06700841 reveal reduction of skin inflammation in plaque psoriasis","volume":"140","author":"Page","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2340\/00015555-3066","article-title":"The keratinocyte transcriptome in psoriasis: pathways related to immune responses, cell cycle and keratinization","volume":"99","author":"Pasquali","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2023.03.1658_bib40","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1158\/0008-5472.CAN-17-0606","article-title":"NDEx 2.0: A clearinghouse for research on cancer pathways","volume":"77","author":"Pratt","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.03.1658_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101937","article-title":"Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1\u03b1, TNF\u03b1 and oncostatin M","volume":"9","author":"Rabeony","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.03.1658_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/09546634.2016.1249820","article-title":"Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)","volume":"28","author":"Reich","year":"2017","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.jid.2023.03.1658_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.jid.5700488","article-title":"Increased expression of Wnt5a in psoriatic plaques","volume":"127","author":"Reischl","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/genes11101155","article-title":"Transcriptome profiling analyses in psoriasis: a dynamic contribution of keratinocytes to the pathogenesis","volume":"11","author":"Rioux","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jid.2023.03.1658_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148450","article-title":"Molecular and cellular profiling of scalp psoriasis reveals differences and similarities compared to skin psoriasis","volume":"11","author":"Ruano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.03.1658_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc3556","article-title":"The DREAM complex: master coordinator of cell cycle-dependent gene expression","volume":"13","author":"Sadasivam","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2023.03.1658_bib47","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1101\/gad.181933.111","article-title":"The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression","volume":"26","author":"Sadasivam","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2023.03.1658_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5826\/dpc.0503a02","article-title":"Diagnostic utility of Ki-67 and cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis","volume":"5","author":"Sezer","year":"2015","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.jid.2023.03.1658_bib49","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.18632\/aging.100988","article-title":"FOXM1 regulates proliferation, senescence and oxidative stress in keratinocytes and cancer cells","volume":"8","author":"Smirnov","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jid.2023.03.1658_bib50","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","article-title":"Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis","volume":"133","author":"Sofen","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib51","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Su\u00e1rez-Fari\u00f1as","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010247","article-title":"Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA)","volume":"5","author":"Su\u00e1rez-Fari\u00f1as","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.03.1658_bib53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13073-015-0208-5","article-title":"Proteogenomic analysis of psoriasis reveals discordant and concordant changes in mRNA and protein abundance","volume":"7","author":"Swindell","year":"2015","journal-title":"Genome Med"},{"key":"10.1016\/j.jid.2023.03.1658_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40169-015-0054-5","article-title":"Psoriasis drug development and GWAS interpretation through in silico\u00a0analysis of transcription factor binding sites","volume":"4","author":"Swindell","year":"2015","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jid.2023.03.1658_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034594","article-title":"Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis","volume":"7","author":"Swindell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.03.1658_bib56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.0022-202x.2001.01610.x","article-title":"Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin","volume":"118","author":"Takeda","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044274","article-title":"Meta-analysis derived (MAD) transcriptome of psoriasis defines the \"core\" pathogenesis of disease","volume":"7","author":"Tian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.03.1658_bib58","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13-dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1658_bib60","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2023.03.1658_bib61","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-4652(199608)168:2<442::AID-JCP23>3.0.CO;2-3","article-title":"Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures","volume":"168","author":"Van Ruissen","year":"1996","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jid.2023.03.1658_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002737","article-title":"Type I interferon: potential therapeutic target for psoriasis?","volume":"3","author":"Yao","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.03.1658_bib63","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:53:09Z","timestamp":1762206789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23019413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0022202X23019413"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.03.1658","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.03.1658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}